GlassScriptPhysician profile
Stacy Blum
NPI 1952757007
$19,234.25
in general payments reported to CMS, 2019-2025
44 companies · $3,097 in 2025
The $3,097 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $851 · 2020: $813 · 2021: $5,899 · 2022: $1,568 · 2023: $2,742 · 2024: $4,265 · 2025: $3,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,783 · Education: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,782.81 |
| Education | $320.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $3,390.43 | 2021 | |
| Abbvie INC. | $3,380.98 | 2019-2025 | Rinvoq, Skyrizi, Vraylar |
| Janssen Biotech, INC. | $1,467.74 | 2020-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,221.22 | 2019-2025 | |
| Lilly USA, LLC | $994.49 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $941.45 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $783.09 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $680.84 | 2022-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $613.62 | 2021-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $608.43 | 2020-2025 | Winlevi, Odomzo, Blu-U |
| Dermavant Sciences, INC. | $599.56 | 2023-2024 | Vtama |
| Amgen INC. | $539.49 | 2021-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $455.19 | 2022-2025 | Sotyktu |
| Incyte Corporation | $326.97 | 2021-2025 | Opzelura |
| Merz North America, INC. | $304.00 | 2022-2025 | Xeomin |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $300.60 | 2022-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $295.28 | 2020-2025 | Aklief, Nemluvio |
| Janssen Scientific Affairs, LLC | $261.78 | 2021-2024 | Tremfya |
| Genzyme Corporation | $255.85 | 2020-2025 | |
| Allergan, INC. | $225.94 | 2020-2022 | |
| Organogenesis INC. | $224.13 | 2024-2025 | Puraply Wound Matrix, Apligraf, Via Matrix |
| Prugen, INC. Pharmaceuticals | $150.00 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.36 | 2020-2025 | Cabtreo, Jublia |
| Mayne Pharma Commercial LLC | $124.11 | 2020-2025 | |
| Organon LLC | $106.87 | 2025 | Vtama, Hadlima |
| Novo Nordisk INC | $98.63 | 2021 | |
| Revance Therapeutics, INC. | $90.93 | 2024 | Daxxify |
| Almirall LLC | $84.16 | 2022-2025 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.40 | 2022-2024 | Spevigo |
| Botanix Sb INC | $71.02 | 2025 | Sofdra |
| Biofrontera INC. | $69.37 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Epi Health, LLC | $51.93 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $43.45 | 2023 | Seglentis |
| Kyowa Kirin, INC. | $43.32 | 2024 | Poteligeo |
| Kerecis Limited | $34.95 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solta Medical, A Division of Bausch Health US, LLC | $25.37 | 2025 | Clear+Brilliant |
| Celgene Corporation | $23.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.94 | 2019 | |
| Sandoz INC. | $22.34 | 2021 | |
| Fidia Pharma USA INC. | $21.86 | 2022 | |
| Journey Medical Corporation | $17.46 | 2025 | |
| Dermira, INC. | $15.21 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $13.79 | 2021 | |
| Dusa Pharmaceuticals, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.